Flesh-eating screwworm outbreak: FDA approves emergency medicine for pets

The action comes as federal and state officials respond to the outbreak of the flesh-eating parasite.

FDA advisers to weigh updated COVID vaccine targeting XFG subvariant

The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 ...
The Healthy @Reader's Digest on MSN

Pre-Packaged Salad Recall Gets an Important Update

It was made for consumers who follow a particular diet, but it underwent an error that could have significant health ...
MSN on MSN

31-state FDA recall of popular ice cream gets an update

Here's what went wrong with these sweet treats found in 27,000 containers from a brand beloved by millions.
TMCnet

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval WATERTOWN, Mass., June 09, 2026 (GLOBE ...

FDA urged to update safety labels on antidepressants

An FDA official told a room of Make America Healthy Again supporters Monday that the agency needs data to make any changes to ...

Smoothie recall update as FDA sets most serious risk level

A Utah-based wholesaler voluntarily recalled a banana smoothie product after it was notified of a potential salmonella risk.
Regulatory Affairs Professionals Society

This Week at FDA: Upcoming Senate markup, first OTC CGM for children, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Morningstar

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease

TOKYO and CAMBRIDGE, Mass., May 8, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period ...